Sourcing knowledge: R&D outsourcing in UK pharmaceuticals

International Journal of Technology Management

Volumn 59, Issue 1-2, 2012, Pages 139-161

  Howells, Jeremy ^a   Gagliardi, Dimitri ^b   Malik, Khaleel ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Knowledge management; Pharmaceuticals research; R D outsourcing; UK

Indexed keywords

KNOWLEDGE MANAGEMENT;

ACTIVITY LEVELS; CONCEPTUAL FRAMEWORKS; INNOVATIVE ACTIVITIES; OPEN INNOVATION; PHARMACEUTICAL INDUSTRY; PHARMACEUTICALS RESEARCHES; RESEARCH AND DEVELOPMENT; RESEARCH OPERATIONS;

OUTSOURCING;

EID: 84862544363     PISSN: 02675730     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJTM.2012.047253     Document Type: Article

References (75)

1. Alchian, A.A. and Demsetz, H. (1972) 'Production, information costs and economic organization', American Economic Review, Vol. 62, No. 5, pp.777-795.
2. Allarakhia, M. and Walsh, S. (2011) 'Managing knowledge assets under conditions of radical change: The case of the pharmaceutical industry', Technovation, Vol. 31, Nos. 2-3, pp.105-117.
3. Amiti, M. and Wei, S-J. (2005) 'Fear of service outsourcing: Is it justified?', Economic Policy, Vol. 20, No. 42, pp.308-347.
4. Arora, A. and Gambardella, A. (1990) 'Complementarity and external linkages: The strategies of the large firms in biotechnology', Journal of Industrial Economics, Vol. 38, No. 4, pp.361-379.
5. Arrow, K.J. (1962) 'Economic welfare and the allocation of resources for inventions', in Nelson, R. (Ed.): The Rate and Direction of Inventive Activity, pp.609-625, Princeton University Press, Princeton.
6. Bianchi, M., Cavaliere, A., Chiaroni, D., Frattini, F. and Chiesa, V. (2011) 'Organisational modes for Open Innovation in the bio-pharmaceutical industry: An exploratory analysis', Technovation, Vol. 31, No. 1, pp.22-33.
7. Bierly, P. and Chakrabarti, A. (1996) 'Generic knowledge strategies in the US pharmaceutical industry', Strategic Management Journal, Vol. 17, Winter Special Issue, pp.123-135.
8. Binns, R. and Driscoll, B. (1998) 'Intellectual property issues in R&D contracts', Pharmaceutical Sciences and Technology Today, Vol. 1, No. 3, pp.95-99.
9. Carter, A.P. (1989) 'Know-how trading as economic exchange', Research Policy, Vol. 18, No. 3, pp.155-163.
10. Casella, G. (1983) 'Leverage and regression through the origin', The American Statistician, Vol. 37, No. 2, pp.147-152.
11. Cavusgil, S.T., Calantone, R.J. and Zhao, Y. (2003) 'Tacit knowledge transfer and firm innovation capability', Journal of Business & Industrial Marketing, Vol. 18, No. 1, pp.6-21.
12. Chesbrough, H. (2003) 'The era of open innovation', MIT Sloan Management Review, Vol. 44, No. 3, pp.35-41.
13. Choi, C.Q. (2008) 'Shire pharmaceuticals: A study in exponential growth', The Scientist, Vol. 22, No. 1, p.58.
14. Cohen, W.M. and Levinthal, D.A. (1990) 'Absorptive capacity: A new perspective on learning and innovation', Administrative Science Quarterly, Vol. 35, No. 1, pp.128-152.
15. Contractor, F.J. and Lorange, P. (2002) Cooperative Strategies and Alliances, pp.493-516, Pergamon, Oxford.
16. Contractor, F.J., Kumar, V. et al. (2010) 'Reconceptualizing the firm in a world of outsourcing and offshoring: The organizational and geographical relocation of high-value company functions', Journal of Management Studies, Vol. 47, No. 8, pp.1417-1433.
17. Della Valle, F. and Gambardella, A. (1993) 'Biological revolution and strategies for innovation in pharmaceutical companies', R&D Management, Vol. 23, No. 4, pp.287-302.
18. DiMasi, J.A., Hansen, R.W. and Grabowski, H.G. (2003) 'The price of innovation: New estimates of drug development costs', Journal of Health Economics, Vol. 22, No. 2, pp.151-185.
19. Doctor, R.N., Newton, D.P. and Pearson, A. (2001) 'Managing uncertainty in research and development', Technovation, Vol. 21, No. 2, pp.79-90.
20. Domberger, S. (1998) The Contracting Organization: A Strategic Guide to Outsourcing, Oxford University Press, Oxford.
21. Easterby-Smith, M., Lyles, M.A. and Tsang, E.W.K. (2008) 'Inter-organizational knowledge transfer: Current themes and future prospects', Journal of Management Studies, Vol. 45, No. 4, pp.677-690.
22. Eisenhauer, J.G. (2003) 'Regression through the origin', Teaching Statistics, Vol. 25, No. 3, pp.76-80.
23. Enkel, E., Gassmann, O. and Chesborough, H. (2009) 'Open R&D and open innovation: Exploring the phenomenon', R&D Management, Vol. 39, No. 4, pp.311-316.
24. Ford, D. and Farmer, D. (1986) 'Make or buy - a key strategic issue', Long Range Planning, Vol. 19, No. 5, pp.54-62.
25. Freeman, C. and Soete, L. (1997) The Economics of Industrial Innovation, 3rd ed., Pinter, London.
26. Gabrowsky, H. and Kyle, M. (2008) 'Mergers and alliances in pharmaceutical: Effects on innovation and R&D productivity', in Gugler, K. and Yurtoglu, B.B. (Eds.): The Economics of Corporate Governance and Mergers, Edward Elgar.
27. Galambos, L. and Sturchio, J. (1996) 'The pharmaceutical industry in the twentieth century: A reappraisal of the sources of innovation', History and Technology, Vol. 13, No. 2, pp.83-100.
28. Gassmann, O. and Reepmeyer, G. (2005) 'Organizing pharmaceutical innovation: From science-based knowledge creators to drug-oriented knowledge brokers', Creativity and Innovation Management, Vol. 14, No. 3, pp.233-245.
29. Gassmann, O., Enkel, E. and Chesborough, H. (2010) 'The future of open innovation', R&D Management, Vol. 40, No. 3, pp.213-221.
30. Graves, S. and Langowitz, N. (1993) 'Innovative productivity and returns to scale in the pharmaceutical industry', Strategic Management Journal, Vol. 14, No. 8, pp.593-605.
31. Grimpe, C. and Kaiser, U. (2010) 'Balancing internal and external knowledge acquisition: The gains and pains from R&D outsourcing', Journal of Management Studies, Vol. 47, No. 8, pp.1483-1509.
32. Groenewegen, P. and Wouters, P. (2004) 'Genomics, ICT and the formation of R&D networks', Genetics and Society, Vol. 23, No. 2, pp.167-185.
33. Grossman, G.M. and Helpman, E. (2005) 'Outsourcing in a global economy', Review of Economic Studies, Vol. 72, No. 1, pp.135-159.
34. Hatonen, J. and Eriksson, T. (2009) '30+ years of research and practice of outsourcing - exploring the past and anticipating the future', Journal of International Management, Vol. 15, No. 2, pp.142-155.
35. Higgins, M.J. and Rodriguez, D. (2006) 'The outsourcing of R&D through acquisitions in the pharmaceutical industry', Journal of Financial Economics, Vol. 80, No. 2, pp.351-383.
36. Howells, J. (1999a) 'Research and technology outsourcing', Technology Analysis & Strategic Management, Vol. 11, No. 1, pp.591-603.
37. Howells, J. (1999b) 'Research and technology outsourcing and innovation systems: An exploratory analysis', Industry and Innovation, Vol. 6, No. 1, pp.111-129.
38. Howells, J. (2002) 'Mind the gap: Information and communication technologies, knowledge activities and innovation in the pharmaceutical industry', Technology Analysis & Strategic Management, Vol. 14, No. 3, pp.335-370.
39. Howells, J. and Neary, I. (1995) Intervention and Technological Innovation: Government and the Pharmaceutical Industry in the UK and Japan, Macmillan, London.
40. Howells, J., Gagliardi, D. and Malik, K. (2008) 'The growth and management of R&D outsourcing: Evidence from UK pharmaceuticals', R&D Management, Vol. 38, No. 2, pp.205-219.
41. Jones, O. (2000) 'Innovation management as a post-modern phenomenon: The outsourcing of pharmaceutical R&D', British Journal of Management, Vol. 11, No. 4, pp.341-356.
42. Kay, N.M. (1984) The Boundaries of the Firm: Critiques, Strategies and Policies, Macmillan, London.
43. Kim, C., Beldona, S. and Contractor, F.J. (2007) 'Alliance and technology networks: An empirical study on technology learning', International Journal of Technology Management, Vol. 38, Nos. 1/2, pp.29-44.
44. Lenox, M. and King, A. (2004) 'Prospects for developing absorptive capacity through internal information provision', Strategic Management Journal, Vol. 25, No. 4, pp.331-345.
45. Liebenau, J.M. (1984) 'International R&D in pharmaceutical firms in the early twentieth century', Business History, Vol. 26, No. 3, pp.329-346.
46. Loveday, D.E.E. (1985) 'Managing change in pharmaceutical industry R&D', Technovation, Vol. 3, No. 2, pp.89-109.
47. Madhavan, R., Koka, B.R. and Prescott, J.E. (1998) 'Networks in transition: How industry events (re)shape interfirm relationships', Strategic Management Journal, Vol. 19, No. 5, pp.439-459.
48. Martínez-Noya, A. and García-Canal, E. (2011) 'Technological capabilities and the decision to outsource/outsource offshore R&D services', International Business Review, Vol. 20, No. 3, pp.264-277
49. Massini, S., Lewin, A.Y., Numagami, T. and Pettigrew, A.M. (2002) 'The evolution of organisational routines among large Western and Japanese firms', Research Policy, Vol. 31, Nos. 8-9, pp.1333-1348.
50. McKelvey, M. (1995) Evolutionary Innovation: The Business of Biotechnology, Oxford University Press, Oxford.
51. McMillan, G.S. and Hamilton, D. (2000) 'Using bibliometrics to measure firm knowledge: An analysis of the US pharmaceutical industry', Technology Analysis & Strategic Management, Vol. 12, No. 4, pp.465-475.
52. Mikkola, J.H. (2003) 'Modularity, component outsourcing, and inter-firm learning', R&D Management, Vol. 33, No. 4, pp.439-454.
53. Mowery, D.C. (1984) 'Firm structure, government policy, and the organization of industrial research: Great Britain and the United States, 1900-1950', Business History Review, Vol. 58, No. 4, pp.504-531.
54. Mudambi, S.M. and Tallman, S. (2010) 'Make, buy or ally? Theoretical perspectives on knowledge process outsourcing through alliances', Journal of Management Studies, Vol. 47, No. 8, pp.1434-1456.
55. Nightingale, P.L. (2000) 'Economies of scale in experimentation: Knowledge and technology in pharmaceutical R&D', Industrial and Corporate Change, Vol. 9, No. 2, pp.315-359.
56. Odagiri, H. (2003) 'Transaction costs and capabilities as determinants of the R&D boundaries of the firm: A case study of the ten largest pharmaceuticals firms in Japan', Managerial and Decision Economics, Vol. 24, Nos. 2-3, pp.187-211.
57. OECD (2002) Frascati Manual: Standard Method Proposed for Surveys of Experimental Research and Development, OECD, Paris.
58. Office for National Statistics (ONS) (2007) Research and Development in UK Businesses 2005, Business Monitor (MA14), HMSO, Norwich.
59. Orsenigo, L., Pammolli, F. and Riccaboni, M. (2001) 'Technological change and network dynamics: Lessons from the pharmaceutical industry', Research Policy, Vol. 30, No. 3, pp.485-508.
60. Pérez-Nordtvedt, L., Kedia, B.L., Datta, D.K. and Rasheed, A.A. (2008) 'Effectiveness and efficiency of cross-border knowledge transfer: An empirical examination', Journal of Management Studies, Vol. 45, No. 4, pp.714-744.
61. Piachaud, B.S. (2002) 'Outsourcing in the pharmaceutical manufacturing process: An examination of the CRO experience', Technovation, Vol. 22, No. 2, pp.81-90.
62. Pisano, G.P. (1990) 'The R&D boundaries of the firm: An empirical analysis', Administrative Science Quarterly, Vol. 35, No. 1, pp.153-176.
63. Pisano, G.P. (1994) 'Knowledge, integration and the locus of learning: An empirical analysis of process development', Strategic Management Journal, Vol. 15, No. S1, pp.85-100.
64. Powell, W.W. (1998) 'Learning from collaboration: Knowledge and networks in the biotechnology and pharmaceutical industries', California Management Review, Vol. 40, No. 3, pp.228-240.
65. Quinn, J.B. (1999). 'Strategic outsourcing: Leveraging knowledge capabilities', Sloan Management Review, Vol. 40, No. 4, pp.9-21.
66. Sanderson, M. (1972) 'Research and the firm in British industry, 1919-39', Social Studies of Science, Vol. 2, No. 2, pp.107-151.
67. Sen, A. and MacPherson, A. (2009) 'Outsourcing, external collaboration, and innovation among US firms in the biopharmaceutical industry', Industrial Geographer, Vol. 6, No. 1, pp.20-36.
68. Sen, A.K. (2009) 'Outsourcing of research and development activities: Evidence from U.S. biopharmaceutical firms', Global Journal of Business Research, Vol. 3, No. 1, pp.73-82.
69. Studt, T. (2003) 'Knowledge management is key to improving drug R&D cycles', R&D Magazine, 18 April.
70. Sutcliffe, K.M. and Zaheer, A. (1998) 'Uncertainty in the transaction environment: An empirical test', Strategic Management Journal, Vol. 19, No. 1, pp.1-23.
71. Thomke, S. and Kuemmerle, W. (2002) 'Asset accumulation, interdependence and technological change: Evidence from pharmaceutical drug discovery', Strategic Management Journal, Vol. 23, No. 7, pp.619-635.
72. Tsai, W. (2001) 'Knowledge transfer in intraorganizational networks: Effects of network position and absorptive capacity on business unit innovation and performance', Academy of Management Journal, Vol. 44, No. 5, pp.996-1040.
73. Ulset, S. (1996) 'R&D outsourcing and contractual governance: An empirical study of commercial R&D projects', Journal of Economic Behaviour & Organization, Vol. 31, No. 1, pp.63-82.
74. Walsh, V., Niosi, J. and Mustar, P. (1995) 'Small-firm formation in biotechnology: A comparison of France, Britain and Canada', Technovation, Vol. 15, No. 5, pp.303-327.
75. Welch, J.A. and Nayak, P.R. (1992) 'Strategic sourcing: A progressive approach to the make-or-buy decision', Academy of Management Executive, Vol. 6, No. 1, pp.23-31.